转化使用本源:瘤和胎盘向向

Abdulaziz A Alobaid1, Maximilian W A Skoda2, Lynda K Harris3

  • 1Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, United Kingdom; Department of Pharmaceutics, Faculty of Pharmacy, Kuwait University, P.O. Box 24923, Safat 13110, Kuwait.

概括

胎盘主导RSGVAKS (RSG) 与乳腺癌细胞结合,显示出比瘤主导CGKRK更大的膜相互作用和破坏. 这表明有针对性癌症治疗的潜力.